Herpes Zoster with Aseptic Meningitis in Immunocompetent Children: A Case Series
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Primary clinical features of rash and neurological complications due to varicella zoster virus (VZV) reactivation are rare in a healthy population, especially in immunocompetent children. Early diagnosis and prompt treatment are delayed often due to their rarity. We present four immunocompetent children with VZV reactivation resulting in aseptic meningitis and herpes zoster affecting multiple cranial and spinal nerves. We reviewed the clinical manifestations, laboratory findings, treatment options and outcome of aseptic meningitis associated VZV reactivation. All patients presented with the typical skin lesion of VZV reactivation and definitive laboratory findings of central nervous system infection, without systemic inflammation. Initial manifestations of VZV reactivation included Ramsay Hunt syndrome, herpes zoster ophthalmicus, and herpes zoster affecting the left thoracic dermatomes 4-5. Intravenous acyclovir was administered and all patients recovered fully without any significant sequelae. VZV reactivation can lead to various neurological complications in immunocompetent children. Early recognition and treatment with acyclovir are important for improving the outcome of neurologic complications of VZV reactivation.
Abstract
Primary clinical features of rash and neurological complications due to varicella zoster virus (VZV) reactivation are rare in a healthy population, especially in immunocompetent children. Early diagnosis and prompt treatment are delayed often due to their rarity. We present four immunocompetent children with VZV reactivation resulting in aseptic meningitis and herpes zoster affecting multiple cranial and spinal nerves. We reviewed the clinical manifestations, laboratory findings, treatment options and outcome of aseptic meningitis associated VZV reactivation. All patients presented with the typical skin lesion of VZV reactivation and definitive laboratory findings of central nervous system infection, without systemic inflammation. Initial manifestations of VZV reactivation included Ramsay Hunt syndrome, herpes zoster ophthalmicus, and herpes zoster affecting the left thoracic dermatomes 4-5. Intravenous acyclovir was administered and all patients recovered fully without any significant sequelae. VZV reactivation can lead to various neurological complications in immunocompetent children. Early recognition and treatment with acyclovir are important for improving the outcome of neurologic complications of VZV reactivation.
참고문헌 (18)
- Gilden DH, "Neurologic complications of the reactivation of varicella-zoster virus", N Engl J Med, 342, pp.635~645 (2000)
- Mueller NH, "Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency", Neurol Clin, 26, pp.675~697 (2008)
- Steiner I, "The neurotropic herpes viruses:herpes simplex and varicella-zoster", Lancet Neurol, 6, pp.1015~1028 (2007)
- Nagel MA, "Complications of varicella zoster virus reactivation", Curr Treat Options Neurol, 15, pp.439~453 (2013)
- Gilden D, "Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment", Lancet Neurol, 8, pp.731~740 (2009)
- Leahy TR, "Varicella zoster virus associated acute aseptic meningitis without exanthem in an immunocompetent 14-year-old boy", Pediatr Infect Dis J, 27, pp.362~363 (2008)
- Habib AA, "Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman", J Neurovirol, 15, pp.206~208 (2009)
- Mpaka M, "Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult", Heart Lung, 37, pp.61~66 (2008)
- Han JY, "Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child", Pediatr Infect Dis J, 30, pp.266~268 (2011)
- Goyal H, "Herpes zoster meningitis with multidermatomal rash in an immunocompetent patient", Am J Emerg Med, 31, pp.1622 e1~1622 e2 (2013)
- Kangath RV, "Herpes zoster as a cause of viral meningitis in immunocompetent patients", BMJ Case Rep, 2013 (2013)
- Gilden D, "The variegate neurological manifestations of varicella zoster virus infection", Curr Neurol Neurosci Rep, 13, pp.374~ (2013)
- Gershon AA, "Advances in the understanding of the pathogenesis and epidemiology of herpes zoster", J Clin Virol, 48(Suppl 1), pp.S2~S7 (2010)
- Pahud BA, "Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine", J Infect Dis, 203, pp.316~323 (2011)
- Baird NL, "Varicella zoster virus (VZV)-human neuron interaction", Viruses, 5, pp.2106~2115 (2013)
- Galea SA, "The safety profile of varicella vaccine: a 10-year review", J Infect Dis, 197, pp.S165~S169 (2008)
- Wootton SH, "The epidemiology of children hospitalized with herpes zoster in Canada: Immunization Monitoring Program, Active (IMPACT), 1991-2005", Pediatr Infect Dis J, 27, pp.112~118 (2008)
- Grahn A, "Varicella-zoster virus infections of the central nervous system–Prognosis, diagnostics and treatment", Journal of Infection, 71, pp.281~293 (2015)